Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin Un-fit Advanced Urothelial Carcinoma: Randomized Phase II Study

NCT01487915 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01487915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01487915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin Un-fit Advanced Urothelial Carcinoma: Randomized Phase II Study
Lead sponsor
Asan Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
Not reported
Enrollment
80 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial carcinoma